[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[S. 747 Introduced in Senate (IS)]

<DOC>






115th CONGRESS
  1st Session
                                 S. 747

       To reauthorize the special diabetes programs for Indians.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                             March 28, 2017

   Mr. Udall introduced the following bill; which was read twice and 
  referred to the Committee on Health, Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL


 
       To reauthorize the special diabetes programs for Indians.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Special Diabetes Program for Indians 
Reauthorization Act of 2017''.

SEC. 2. FINDINGS.

    Congress finds that:
            (1) American Indians and Alaska Natives are 
        disproportionately affected by diabetes.
            (2) Approximately 16 percent of American Indian and Alaska 
        Native people have diabetes compared to only 12 percent of the 
        general United States population.
            (3) The death rate due to diabetes for American Indians and 
        Alaska Natives is 1.6 times higher than for the general 
        population.
            (4) In response to the growing epidemic of diabetes among 
        Native communities, Congress authorized the Special Diabetes 
        Programs for Indians in 1997.
            (5) Since the first authorization, the Special Diabetes 
        Programs for Indians have--
                    (A) made it possible for Native communities to 
                develop and sustain quality diabetes treatment and 
                prevention programs, including--
                            (i) a 40-percent increase in number of 
                        diabetes clinics;
                            (ii) a 42-percent increase in access to 
                        registered nutritionists; and
                            (iii) a 61-percent increase in availability 
                        of culturally tailored education programs;
                    (B) resulted in concrete health outcomes, like a 
                48-percent decrease in end-stage renal disease among 
                American Indian and Alaska Native populations; and
                    (C) led to millions of dollars in healthcare cost 
                savings by decreasing the prevalence of costly 
                preventable diabetes complications.
            (6) Due to the continued positive impact of the Special 
        Diabetes Programs for Indians on Native communities and the 
        large return on investment for healthcare funding, Congress has 
        shown its support for the programs by--
                    (A) reauthorizing the Special Diabetes Programs for 
                Indians no less than 8 times; and
                    (B) sending letters of support for the Special 
                Diabetes Programs to Congressional leadership signed by 
                more than 350 Representatives and 75 Senators.

SEC. 3. REAUTHORIZATION OF THE SPECIAL DIABETES PROGRAMS FOR INDIANS.

    Section 330C(c) of the Public Health Service Act (42 U.S.C. 254c-
3(c)) is amended by striking paragraph (2) and inserting the following:
            ``(2) Appropriations.--
                    ``(A) In general.--For the purpose of making grants 
                under this section, there is appropriated, out of any 
                money in the Treasury not otherwise appropriated--
                            ``(i) $150,000,000 for fiscal year 2018; 
                        and
                            ``(ii) the amount specified in subparagraph 
                        (B) for each of fiscal years 2019 through 2024.
                    ``(B) Inflation adjustment.--
                            ``(i) In general.--In the case of any of 
                        fiscal years 2019 through 2024, the dollar 
                        amount in subparagraph (A)(i) shall be 
                        increased by an amount equal to the product 
                        of--
                                    ``(I) such dollar amount; and
                                    ``(II) the percentage increase in 
                                the medical care component of the 
                                consumer price index for the previous 
                                fiscal year as calculated by United 
                                States Bureau of Labor Statistics.
                            ``(ii) Rounding.--If the amount of any 
                        increase under clause (i) is not a multiple of 
                        $10, such increase shall be rounded to the next 
                        lowest multiple of $10.''.
                                 <all>